Chromocell Therapeutics Corporation merged with its subsidiary Channel Therapeutics Corporation, becoming the surviving entity and changing its name, effective November 18, 2024, while assuming all prior liabilities and obligations.
AI Assistant
PELTHOS THERAPEUTICS INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.